Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Jun 12 2026

Full Issue

More Teens, Young Adults Turning To AI Chatbots For Mental Health Support

A study finds that 20% of people aged 12 to 21 have used artificial intelligence tools for advice on their mental health. Other research news looks at flu shots, cancer, heart health, and more.

CNN: Nearly 20% Of Young People Use AI Chatbots For Mental Health Help 

When today’s teenagers and young adults are struggling emotionally, some are turning not only to friends, family members and therapists but also to artificial intelligence. Nearly 1 in 5 adolescents and young adults have used AI chatbots for advice or help when they felt upset, nervous or anxious, according to a new study published June 1 in JAMA Pediatrics. (Hetter, 6/11)

CIDRAP: People Who Received Flu Shots 40% Less Likely To Test Positive For Influenza, New Data Show

A new study finds that flu shots were associated with moderate protection against the virus during the 2024-25 flu season. People vaccinated against influenza that season were 40% less likely to test positive for flu than unvaccinated people, according to a study of more than 1.1 million Californians. (Szabo, 6/11)

MedPage Today: Chemo-Free Treatment Effective In Kids With Aggressive Blood Cancer

A chemotherapy-free regimen was safe and effective in pediatric patients with newly diagnosed acute promyelocytic leukemia (APL), according to results from a prospective study. The 2-year overall survival (OS) rate among all 114 patients in the study was 99.1%, reported Franco Locatelli, MD, PhD, of IRCCS Bambino Gesù Children's Hospital in Rome, during a session at the European Hematology Association annual congress in Stockholm. (Bassett, 6/11)

MedPage Today: Trial: Vitamin K Supplement Curbs Coronary Atherosclerosis

Menaquinone-7 (MK-7) supplementation modestly slowed the progression of coronary artery calcification (CAC) for patients in the placebo-controlled VitaK-CAC trial. (Lou, 6/11)

Studies in lifestyle and wellness —

Fox News: Specific Gut Microbe May Help Maintain Weight Loss Goals, Study Reveals

A specific gut microbe could help with long-term weight loss goals. New research published in the journal Nature Medicine tested whether a pasteurized (not live) gut bacterium called Akkermansia muciniphila MucT could help people keep weight off after losing it. (Stabile, 6/11)

The Washington Post: The Midlife Habits That Could Make Or Break Your Brain Health Long-Term

Neuroscientist Miia Kivipelto’s life’s work has been about preventing dementia. Now, at 52, she has begun thinking more about her own vulnerability. “Midlife is the time,” said Kivipelto, a neuroscientist who recently joined the Yale School of Nursing as the inaugural director of its Center for Aging Well in New Haven, Connecticut. “It’s the last best chance to lower risk.” (Eunjung Cha, 6/11)

MedPage Today: Is Microdosing Accutane Safe? Dermatologist Weighs In

While isotretinoin (Accutane) is an incredibly effective acne medication, the intense side effects lead some patients to microdose the medication off-label. Isotretinoin is a very concentrated form of vitamin A that shrinks the sebaceous glands, reducing oil production, and is most often prescribed for acne, explained Raman Madan, MD, a dermatologist with Northwell Health in Glen Cove, New York, in an interview with MedPage Today in which a press person was also present. (Robertson, 6/11)

Also —

The New York Times: The Researcher Who Didn’t Want To Know

On my second visit with Nancy Wexler at her Manhattan apartment, she had a gift for me. It was a copy of her newly published memoir, “My Life, My Science: Pursuing a Cure for Huntington’s Disease.” It had been signed with a stamp of her signature — she isn’t able to sign it herself. Nor could she rise from her brown faux-leather recliner to greet me — she can’t get up unassisted. Speaking requires effort. She can manage at most a few badly slurred words or phrases or, with great difficulty, a short sentence. (Kolata, 6/11)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, June 12
  • Thursday, June 11
  • Wednesday, June 10
  • Tuesday, June 9
  • Monday, June 8
  • Friday, June 5
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF